COVID-19 Reports

IDM worked closely with universities and departments of public health to conduct research and analysis on the COVID-19 pandemic that helped inform COVID-19 response efforts. Work presented here originates from IDM’S disease modeling research unless otherwise stated and attributed. All report results should be considered preliminary until published in a peer-reviewed research journal, at which point it will be added to the Publications page.

Search

Filter

Topic

Bradley G. Wagner, Prashanth Selvaraj, and Stewart T. Chang

PDF | March 25, 2021

This 5th report gives a validated method and predictive subnational results for selection of vaccine-trial sites based on future COVID-19 incidence.
Bradley G. Wagner, Prashanth Selvaraj, and Stewart T. Chang

PDF | February 24, 2021

This report (4th in the series) provides a validated method and predictive subnational results for selection of vaccine-trial sites based on future COVID-19 incidence.
Daniel J. Klein, Cliff C. Kerr, Dina Mistry, Edward A. Wenger, and Jamie A. Cohen

PDF | February 24, 2021

The fourth report in the series, this report uses Covasim to look at health risks for COVID introductions into schools, subsequent outbreaks within schools, and exportation into the community.
Bradley G. Wagner, Prashanth Selvaraj, and Stewart T. Chang

PDF | January 29, 2021

This report provides a validated method and predictive subnational results for selection of vaccine-trial sites based on future COVID-19 incidence. It will be updated regularly (this is #3 in the series).
Rafael C. Nunez, Mike Famulare, Vincent Seaman, and Daniel J. Klein

PDF | January 27, 2021

Effective control of COVID-19 requires implementing the mix of NPIs best suited to the demographics, dominant industry, and other county-specific characteristics of a location.
Roy Burstein, Mike Famulare, Niket Thakkar

PDF | January 19, 2021

This report provides a simple method to estimate COVID-19 prevalence using readily available data on test positivity and cases per capita.
Ian Painter, Gitanjali Singh, Juan M. Lavista Ferres, Ruth Etzioni, Barbra A. Richardson, Cathy Wasserman

PDF | December 23, 2020

Data through Dec 11 indicate that Re is still above one across eastern and western Washington.
Bradley G. Wagner, Prashanth Selvaraj, and Stewart T. Chang

PDF | December 18, 2020

This report provides temporally updated results for the Nov 13 report ranking COVID-19 vaccine trial sites.
Niket Thakkar, Roy Burstein, and Mike Famulare

PDF | December 16, 2020

A new method that works in concert with IDM’s transmission model to jointly estimate weekly COVID-19 prevalence and incidence for 15 regions across WA state.
Ian Painter, Gitanjali Singh, Juan M. Lavista Ferres, Ruth Etzioni, Barbra A. Richardson, Niket Thakkar, Greer Fowler, Mike Famulare, Cathy Wasserman

HTML | December 9, 2020

Data through Nov 20 indicate that Re is likely 1.44 for western Washington and 1.33 in eastern Washington.